CURE Pharmaceutical Closes $10 Million Financing
11/02/20, 1:05 PM
Location
oxnard
Money raised
$10 million
CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the “Notes”). Axiom Capital Management, Inc. acted as the sole placement agent in the transaction.